摘要
目的探究克林霉素联合氨曲南对盆腔炎性疾病患者血清炎性因子水平的影响。方法选择2014年3月~2016年3月我院收治的盆腔炎性疾病患者70例,随机分为两组,各35例。对照组实施克林霉素治疗,观察组实施克林霉素联合氨曲南治疗。比较两组患者血清炎性因子水平。结果观察组患者的IL-6、WBC计数、TNF-α、hsCRP水平均低于对照组,差异有统计学意义（P〈0.05）。结论克林霉素联合氨曲南治疗盆腔炎性疾病效果显著,能有效改善患者的血清炎性因子水平。
Objective To investigate the effect of clindamycin（CLDM） combined with aztreonam on the level of serum inflammatory factor of patients with pelvic inflammatory disease（PID）. Methods 70 PID patients admitted into the hospital from March 2014 to March 2016 were randomly divided into two groups, 35 cases in each. Control group took CLDM, observation group took CLDM combined with aztreonam. The levels of serum inflammatory factor of two groups were compared. Results The IL-6, WBC count, TNF-α, hs-CRP level of observation group were significantly lower than control group（P〈0.05）. Conclusion CLDM combined withaztreonam for PID has significant effects and can effectively improve the level of serum inflammatory factor.
出处
《中国继续医学教育》
2016年第30期130-131,共2页
China Continuing Medical Education
关键词
克林霉素
氨曲南
盆腔炎性疾病
血清炎性因子
Clindamycin
Aztreonam
Pelvic inflammatory disease
Serum inflammatory factor
